CymaBay Therapeutics Inc. (CBAY) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Sat March 27th, 2021

- 05:30
  EarningsAnalysisCymaBay Therapeutics Inc. (CBAY) Q4 2020 Earnings Call TranscriptThe Motley Fool

Fri March 26th, 2021

- 05:18
  EarningsAnalysisCymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Wed March 17th, 2021

- 18:34
  AnalysisCymaBay Therapeutics (CBAY) Investor Presentation - SlideshowSeeking Alpha

Wed February 17th, 2021

- 15:54
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisCymaBay Therapeutics: Checking In On This Roller Coaster StockSeeking Alpha

Tue November 17th, 2020

- 19:26
  AnalysisCymaBay Therapeutics (CBAY) Presents At AASLD 2020 Conference- SlideshowSeeking Alpha

Sat November 14th, 2020

- 13:48
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisStocks To Watch: Spotlight On Nvidia, Walmart, JD.com And NioSeeking Alpha

Sun November 8th, 2020

- 21:11
  AnalysisCymaBay Is Clawing Back, Now We Just Need Pipeline ConversionSeeking Alpha
- 21:09
  EarningsAnalysisCymaBay Therapeutics, Inc. 2020 Q3 - Results - Earnings Call PresentationSeeking Alpha

Sat November 7th, 2020

- 17:22
  EarningsAnalysisCymaBay Therapeutics (CBAY) CEO Sujal Shah on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Wed September 30th, 2020

- 13:58
  AnalysisImplied Volatility Surging for CymaBay Therapeutics (CBAY) Stock OptionsZacks

Fri September 11th, 2020

- 18:58
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  IPOAnalysisIPO Update: Metacrine Seeks $85 Million U.S. IPOSeeking Alpha

Thu August 13th, 2020

- 18:39
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideViking Therapeutics: Another Year In ReviewSeeking Alpha

Tue August 11th, 2020

- 07:01
  EarningsAnalysisCymaBay Therapeutics Inc. (CBAY) Q2 2020 Earnings Call TranscriptThe Motley Fool
- 03:29
  EarningsAnalysisCymaBay Therapeutics, Inc.'s (CBAY) CEO Sujal Shah on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon August 3rd, 2020

- 13:31
  Press ReleasesAnalysisThinking about buying stock in CymaBay Therapeutics, Trevena Inc, Co-Diagnostics, Plug Power, or Aurora Cannabis?PR Newswire

Thu July 23rd, 2020

- 14:35
  Press ReleasesAnalysisThinking about buying stock in Milestone Pharmaceuticals, Advanced Micro Devices, CymaBay Therapeutics, Pfizer Inc, or AT&T?PR Newswire

Thu June 25th, 2020

- 18:34
  AnalysisCymaBay: Live And Die By The FDASeeking Alpha

Tue June 23rd, 2020

- 18:32
  AnalysisCymaBay Seladelpar Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Thu June 18th, 2020

- 12:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisIs the Options Market Predicting a Spike in CymaBay (CBAY) Stock?Zacks

Tue June 2nd, 2020

- 14:22
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay TherapeuticsZacks

SPY$395.63-3.9%

QQQ$315.85-6.3%

DOW$64.141.6%

GME$178.513%

NDAQ$149.79-4%

TSLA$621.3-8.2%

SPY$395.63-3.9%

QQQ$315.85-6.3%

DOW$64.141.6%

GME$178.513%

NDAQ$149.79-4%

TSLA$621.3-8.2%

About Developer Contact